InfuSystem Holdings, Inc. (NYSE:INFU - Get Free Report)'s stock price shot up 2.6% during trading on Wednesday . The stock traded as high as $6.30 and last traded at $6.29. 70,000 shares changed hands during trading, a decline of 40% from the average session volume of 116,204 shares. The stock had previously closed at $6.13.
Wall Street Analysts Forecast Growth
Several equities research analysts have issued reports on the stock. Wall Street Zen lowered shares of InfuSystem from a "strong-buy" rating to a "buy" rating in a report on Wednesday, May 14th. Sidoti raised shares of InfuSystem to a "strong-buy" rating in a research report on Tuesday, March 18th. Finally, B. Riley upgraded shares of InfuSystem to a "strong-buy" rating in a report on Thursday, May 8th.
Read Our Latest Report on InfuSystem
InfuSystem Price Performance
The firm has a market cap of $124.84 million, a price-to-earnings ratio of 99.02 and a beta of 1.81. The business's 50-day simple moving average is $5.89 and its two-hundred day simple moving average is $6.47. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50.
Institutional Investors Weigh In On InfuSystem
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Bank of New York Mellon Corp lifted its stake in shares of InfuSystem by 14.3% in the 4th quarter. Bank of New York Mellon Corp now owns 91,219 shares of the company's stock worth $771,000 after purchasing an additional 11,436 shares during the period. First Eagle Investment Management LLC grew its holdings in shares of InfuSystem by 25.9% in the fourth quarter. First Eagle Investment Management LLC now owns 908,371 shares of the company's stock valued at $7,676,000 after purchasing an additional 186,668 shares in the last quarter. Summit Global Investments bought a new stake in InfuSystem in the fourth quarter worth $86,000. Sei Investments Co. bought a new stake in InfuSystem in the fourth quarter worth $90,000. Finally, WINTON GROUP Ltd bought a new stake in shares of InfuSystem during the fourth quarter worth $164,000. 71.13% of the stock is currently owned by institutional investors.
About InfuSystem
(
Get Free Report)
InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.
Recommended Stories
Before you consider InfuSystem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InfuSystem wasn't on the list.
While InfuSystem currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
